BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Gilead Speeds Manufacture of Experimental COVID-19 Drug, Doesn’t Plan to Charge

  One of the promising experimental drugs being tested to treat COVID-19, the disease caused by the novel coronavirus SARS-Cov2-, is Gilead Sciences’ remdesivir.

  April 5, 2020

   · 

  4 min read

   · 

  Mark Terry
• Business

  Yuyu Pharma appoints Robert Wonsang Yu as incoming President and CEO

  Yuyu Pharma, a global pharmaceutical company based in Korea, is pleased to announce the appointment of Mr. Robert Wonsang Yu as President and Chief Executive Officer effective April 6, 2020..

  April 5, 2020

   · 

  1 min read
• Policy

  3M Responds to Inaccurate Reporting on Alleged Seizure of N95 Respirator Shipments

  3M issued the following statement in response to inaccurate media reports alleging a shipment of 3M personal protective equipment was seized and diverted by U.S. authorities on Friday, April 3, while in transit from a 3M China facility to Berlin Police

  April 5, 2020

   · 

  1 min read
• Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment

  Samsung Biologics entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline, a next generation therapeutic antibody candidate to treat oncology and neovascular disorders.

  April 5, 2020

   · 

  2 min read
• Drug Development

  Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutionizing Atopic Dermatitis Virtual Symposium

  Incyte announced the first presentation of Phase 3 data for ruxolitinib cream in atopic dermatitis at the Revolutionizing Atopic Dermatitis Virtual Symposium.

  April 5, 2020

   · 

  9 min read
• BioMidwest

  United Imaging Releases Information on Additional Transportable CTs for the U.S.

  Company Works with Sea Box to Develop Another Portable Option Designed to Meet Coronavirus-related Demand

  April 5, 2020

   · 

  3 min read
• Infinitus Scales-up Health Literacy Initiative for World Health Day

  With World Health Day fast approaching on April 7, Infinitus Company Ltd., a purveyor of health products and solutions, taps into its vast products, services and wealth of knowledge to improve health literacy of larger population.

  April 5, 2020

   · 

  3 min read